B. Woodcock

Individual variation in daily dosage requirements for phenytoin sodium in patients with epilepsy.

G. Mawer, M. H. Barot, R. Grant, 1978, British journal of clinical pharmacology.

Transdermal nicotine in smoking cessation and involvement of non-specific influences.

B. Keller-Stanislawski, N. Rietbrock, B. Woodcock, 1993, International journal of clinical pharmacology, therapy, and toxicology.

Effect of posture on glyceryl trinitrate plasma concentrations following transdermal application.

B. Woodcock, R. Heidemann, C. Beckenbauer, 1987, British journal of clinical pharmacology.

Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man.

S. Rietbrock, D. Acerbi, N. Rietbrock, 1993, European journal of rheumatology and inflammation.

Can digoxin dose requirements be predicted?

S. B. Lucas, S. Dobbs, G. Mawer, 1976, British journal of clinical pharmacology.

The pharmacological properties and clinical use of valdecoxib, a new cyclo‐oxygenase‐2‐selective inhibitor

G. Geisslinger, M. Burian, B. Woodcock, 2003, Alimentary pharmacology & therapeutics.

Non-bioequivalence of sublingual nifedipine [letter]

M. Kausch, N. Rietbrock, B. Woodcock, 1987 .